Search

everythinglearnresearchcommunity

for

Search:↓

Narrowband Ultraviolet B treatment can significantly reduce anxiety in psoriasis patients, but it doesn't significantly affect depression.

More hair loss leads to higher risk of psychosexual disorders, especially in women.

Many patients with Alopecia Areata in Korea experience anxiety, depression, and reduced quality of life, which are often unrelated to the severity of hair loss.

Alopecia areata mainly affects young people and has significant psychological impacts, especially in males.

Skin symptoms without a medical cause often reflect psychological stress and are influenced by culture, requiring a team approach for treatment.

Finasteride users have a very low risk of mental health issues, but those with hair loss may have slightly higher anxiety and depression.

Alopecia Areata patients experience higher social appearance anxiety due to visible hair loss.

Alopecia negatively affects quality of life and mental health.

Cognitive-behavioral therapy is the best treatment for hair-pulling disorder, and combining it with other therapies could improve results.

Trichotillomania treatment is improving with behavior therapy and new drug approaches, but challenges like stigma and underdiagnosis remain.

Finasteride helps reduce priapism in sickle cell anemia patients.

Peripheral treatments showed some improvement in sexual dysfunction, but central symptoms remain challenging.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Lower illness acceptance is linked to more body dysmorphic disorder symptoms in patients with body modifications.

5-alpha reductase inhibitors may increase depression risk by 31%, but results vary based on comparison groups.

People with hair loss conditions like Telogen Effluvium and Alopecia Areata often feel scalp pain and are more likely to have anxiety, but not necessarily depression.

The conclusion is that self-concept, shame, and emotion regulation are key factors in hoarding disorder, body dysmorphic disorder, and trichotillomania, and should be targeted in treatment and research.

Women with PCOS often try to lose weight and see themselves as overweight, regardless of their actual BMI.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Many women using contraception in Mukalla, Yemen, experience side effects like hair loss and mood swings, needing personalized care.

Risankizumab may help manage symptoms of dissecting cellulitis of the scalp.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

Women with alopecia often experience high levels of anxiety and depression, needing psychiatric help.

Men may experience long-term sexual dysfunction after stopping Finasteride.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

The document concludes that Passiflora incarnata could help with anxiety, telemedicine might improve heart failure care, screen time for kids has increased, pregnant teens in Brazil are mostly okay with their body image, rare tuberculosis infection can occur after knee surgery, older and severely ill people are more likely to have long COVID-19 symptoms, HPLC might diagnose more diabetes cases, and psychiatrists should be involved in pain management.

People with hidradenitis suppurativa have a higher risk of heart attacks and strokes.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Psychological factors play a significant role in developing alopecia areata.